Infinity Pharmaceuticals, Inc.

INFIQ · OTC
Analyze with AI
6/30/2023
3/31/2023
12/31/2022
9/30/2022
Assets
Cash & Equivalents$17,746$25,737$38,313$47,182
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$377$590$560$403
Total Curr. Assets$19,908$28,363$40,302$49,350
Property Plant & Equip (Net)$1,082$1,292$1,497$1,699
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$158$158$158$158
Tax Assets$0$0$0$0
Other NC Assets$84$138$194$384
Total NC Assets$1,324$1,588$1,849$2,241
Other Assets$0$0$0$0
Total Assets$21,232$29,951$42,151$51,591
Liabilities
Payables$1,502$1,935$4,405$1,952
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$6,942$0$0
Other Curr. Liab.$2,877$3,003$2,478$5,078
Total Curr. Liab.$12,064$11,289$13,628$14,200
LT Debt$0$0$47,213$47,753
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$46,820$37$32
Total NC Liab.$46,574$46,984$47,574$48,265
Other Liabilities$0$0$0$0
Cap. Leases$633$777$917$480
Total Liabilities$58,638$58,273$61,202$62,465
Equity
Pref Stock$0$0$0$0
Common Stock$90$89$89$89
Retained Earnings-$876,953-$866,997-$855,952-$846,722
AOCI$0$0$0$0
Other Equity$0$0$0$0
Total Equity-$37,406-$28,322-$19,051-$10,874
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$21,232$29,951$42,151$51,591
Net Debt-$17,746-$25,737$8,900$571
Infinity Pharmaceuticals, Inc. (INFIQ) Financial Statements & Key Stats | AlphaPilot